{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T06:06:46Z","timestamp":1789538806624,"version":"build-2803163510"},"reference-count":123,"publisher":"Elsevier","isbn-type":[{"value":"9780128171431","type":"print"}],"license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1016\/bs.acc.2018.10.005","type":"book-chapter","created":{"date-parts":[[2018,11,16]],"date-time":"2018-11-16T18:31:04Z","timestamp":1542393064000},"page":"91-119","source":"Crossref","is-referenced-by-count":46,"title":["Novel glomerular filtration markers"],"prefix":"10.1016","member":"78","reference":[{"key":"10.1016\/bs.acc.2018.10.005_bb0010","series-title":"Your-Kidneys\/Prevent\/What-Your-Kidneys-Do","author":"Kidney Health Australia","year":"2018"},{"key":"10.1016\/bs.acc.2018.10.005_bb0015","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S0140-6736(13)60687-X","article-title":"Chronic kidney disease: global dimension and perspectives","volume":"382","author":"Jha","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/bs.acc.2018.10.005_bb0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0158765","article-title":"Global prevalence of chronic kidney disease\u2014a systematic review and meta-analysis","volume":"11","author":"Hill","year":"2016","journal-title":"PLoS One"},{"issue":"7 Suppl. 2","key":"10.1016\/bs.acc.2018.10.005_bb0025","doi-asserted-by":"crossref","first-page":"S131","DOI":"10.1097\/01.ASN.0000070152.11927.4A","article-title":"Prevalence of kidney damage in Australian adults: the AusDiab kidney study","volume":"14","author":"Chadban","year":"2003","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/bs.acc.2018.10.005_bb0030","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1046\/j.1523-1755.2002.00356.x","article-title":"Albuminuria and renal insufficiency prevalence guides population screening: results from the NHANES III","volume":"61","author":"Garg","year":"2002","journal-title":"Kidney Int."},{"issue":"2 Suppl. 1","key":"10.1016\/bs.acc.2018.10.005_bb0035","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification","volume":"39","author":"National Kidney Foundation","year":"2002","journal-title":"Am. J. Kidney Dis."},{"issue":"3","key":"10.1016\/bs.acc.2018.10.005_bb0040","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1053\/j.ajkd.2014.04.010","article-title":"Measuring GFR: a systematic review","volume":"64","author":"Soveri","year":"2014","journal-title":"Am. J. Kidney Dis."},{"issue":"1","key":"10.1016\/bs.acc.2018.10.005_bb0045","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1053\/j.ackd.2017.10.004","article-title":"Estimated glomerular filtration rate from a panel of filtration markers-hope for increased accuracy beyond measured glomerular filtration rate?","volume":"25","author":"Inker","year":"2018","journal-title":"Adv. Chronic Kidney Dis."},{"key":"10.1016\/bs.acc.2018.10.005_bb0050","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.2215\/CJN.10311013","article-title":"Urea and ammonia metabolism and the control of renal nitrogen excretion","volume":"10","author":"Weiner","year":"2015","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/bs.acc.2018.10.005_bb0055","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1080\/10408363.2018.1427041","article-title":"Endogenous markers for kidney function in children: a review","volume":"55","author":"den Bakker","year":"2018","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"10.1016\/bs.acc.2018.10.005_bb0060","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1373\/clinchem.2011.167494","article-title":"Established and emerging markers of kidney function","volume":"58","author":"Ferguson","year":"2012","journal-title":"Clin. Chem."},{"key":"10.1016\/bs.acc.2018.10.005_bb0065","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000180580","article-title":"Prediction of creatinine clearance from serum creatinine","volume":"16","author":"Cockcroft","year":"1976","journal-title":"Nephron"},{"key":"10.1016\/bs.acc.2018.10.005_bb0070","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/01.mnh.0000222695.84464.61","article-title":"Kidney function estimating equations: where do we stand?","volume":"15","author":"Coresh","year":"2006","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10.1016\/bs.acc.2018.10.005_bb0075","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group","volume":"130","author":"Levey","year":"1999","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/bs.acc.2018.10.005_bb0080","doi-asserted-by":"crossref","first-page":"247","DOI":"10.7326\/0003-4819-145-4-200608150-00004","article-title":"Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate","volume":"145","author":"Levey","year":"2006","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/bs.acc.2018.10.005_bb0085","doi-asserted-by":"crossref","first-page":"906","DOI":"10.2215\/CJN.10931210","article-title":"Are the creatinine-based equations accurate to estimate glomerular filtration rate in African American populations?","volume":"6","author":"Delanaye","year":"2011","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/bs.acc.2018.10.005_bb0090","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/bs.acc.2018.10.005_bb0095","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1093\/ndt\/gft006","article-title":"Con: should we abandon the use of the MDRD equation in favour of the CKD-EPI equation?","volume":"28","author":"Delanaye","year":"2013","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/bs.acc.2018.10.005_bb0100","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/ki.2010.462","article-title":"Evaluation of the chronic kidney disease epidemiology collaboration equation for estimating the glomerular filtration rate in multiple ethnicities","volume":"79","author":"Stevens","year":"2011","journal-title":"Kidney Int."},{"key":"10.1016\/bs.acc.2018.10.005_bb0105","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1053\/j.ajkd.2013.03.027","article-title":"Update on cystatin C: incorporation into clinical practice","volume":"62","author":"Shlipak","year":"2013","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/bs.acc.2018.10.005_bb0110","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1053\/j.ajkd.2016.07.021","article-title":"Non-GFR determinants of low-molecular-weight serum protein filtration markers in CKD","volume":"68","author":"Liu","year":"2016","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/bs.acc.2018.10.005_bb0115","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1373\/clinchem.2016.264325","article-title":"Multicenter evaluation of cystatin C measurement after assay standardization","volume":"63","author":"Bargnoux","year":"2017","journal-title":"Clin. Chem."},{"key":"10.1016\/bs.acc.2018.10.005_bb0120","doi-asserted-by":"crossref","first-page":"888","DOI":"10.5858\/arpa.2014-0427-CP","article-title":"Performance in measurement of serum cystatin C by laboratories participating in the College of American Pathologists 2014 CYS survey","volume":"139","author":"Eckfeldt","year":"2015","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/bs.acc.2018.10.005_bb0125","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/ki.1979.128","article-title":"Renal filtration, transport, and metabolism of low-molecular-weight proteins: a review","volume":"16","author":"Maack","year":"1979","journal-title":"Kidney Int."},{"key":"10.1016\/bs.acc.2018.10.005_bb0130","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/S0140-6736(66)92190-8","article-title":"The transmission of immunity from mother to young and the catabolism of immunoglobulins","volume":"288","author":"Brambell","year":"1966","journal-title":"Lancet"},{"key":"10.1016\/bs.acc.2018.10.005_bb0135","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1084\/jem.20021829","article-title":"The major histocompatibility complex-related Fc receptor for IgG (FcRn) binds albumin and prolongs its lifespan","volume":"197","author":"Chaudhury","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/bs.acc.2018.10.005_bb0140","doi-asserted-by":"crossref","first-page":"4595","DOI":"10.4049\/jimmunol.1403014","article-title":"FcRn: the architect behind the immune and nonimmune functions of IgG and albumin","volume":"194","author":"Pyzik","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/bs.acc.2018.10.005_bb0145","doi-asserted-by":"crossref","first-page":"4983","DOI":"10.1021\/bi052628y","article-title":"Albumin binding to FcRn: distinct from the FcRn-IgG interaction","volume":"45","author":"Chaudhury","year":"2006","journal-title":"Biochemistry"},{"key":"10.1016\/bs.acc.2018.10.005_bb0150","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1681\/ASN.2008090976","article-title":"Renal FcRn reclaims albumin but facilitates elimination of IgG","volume":"20","author":"Sarav","year":"2009","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/bs.acc.2018.10.005_bb0155","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/0272-6386(95)90058-6","article-title":"Proximal tubular cell synthesis and secretion of endothelin-1 on challenge with albumin and other proteins","volume":"26","author":"Zoja","year":"1995","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/bs.acc.2018.10.005_bb0160","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1093\/ndt\/16.9.1769","article-title":"Regulation of endothelin-1 and transforming growth factor-beta1 production in cultured proximal tubular cells by albumin and heparan sulphate glycosaminoglycans","volume":"16","author":"Yard","year":"2001","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/bs.acc.2018.10.005_bb0165","doi-asserted-by":"crossref","first-page":"F1397","DOI":"10.1152\/ajprenal.90313.2008","article-title":"Complement activation by tubular cells is mediated by properdin binding","volume":"295","author":"Gaarkeuken","year":"2008","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/bs.acc.2018.10.005_bb0170","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1681\/ASN.2012111112","article-title":"NADPH oxidases, reactive oxygen species, and the kidney: friend and foe","volume":"24","author":"Sedeek","year":"2013","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/bs.acc.2018.10.005_bb0175","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1681\/ASN.V114632","article-title":"Characterization and localization of the neonatal Fc receptor in adult human kidney","volume":"11","author":"Haymann","year":"2000","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/bs.acc.2018.10.005_bb0180","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1681\/ASN.V991723","article-title":"Beta-2 microglobulin in renal disease","volume":"9","author":"Miyata","year":"1998","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/bs.acc.2018.10.005_bb0185","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1172\/JCI106083","article-title":"Differentiation of glomerular, tubular, and normal proteinuria: determinations of urinary excretion of beta-2-macroglobulin, albumin, and total protein","volume":"48","author":"Peterson","year":"1969","journal-title":"J. Clin. Invest."},{"key":"10.1016\/bs.acc.2018.10.005_bb0190","first-page":"43","article-title":"Beta 2 microglobulin. Index of glomerular filtration in children","volume":"41","author":"Leroy","year":"1984","journal-title":"Arch. Fr. Pediatr."},{"key":"10.1016\/bs.acc.2018.10.005_bb0195","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2017.00073","article-title":"Rediscovering beta-2 microglobulin as a biomarker across the spectrum of kidney diseases","volume":"4","author":"Argyropoulos","year":"2017","journal-title":"Front. Med."},{"key":"10.1016\/bs.acc.2018.10.005_bb0200","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/j.clinbiochem.2009.06.030","article-title":"Performance characteristics of beta-2-microglobulin measurements on a Beckman Immage analyzer with the DakoCytomation reagent kit","volume":"42","author":"De","year":"2009","journal-title":"Clin. Biochem."},{"key":"10.1016\/bs.acc.2018.10.005_bb0205","first-page":"131","article-title":"Evaluation of a sensitive immunoluminometric assay for the determination of C-reactive protein (CRP) in serum and plasma and the establishment of reference ranges for different groups of subjects","volume":"46","author":"Wood","year":"2000","journal-title":"Clin. Lab."},{"key":"10.1016\/bs.acc.2018.10.005_bb0210","first-page":"492","article-title":"International staging system required standardization of biochemical laboratory testing in multiple myeloma","volume":"53","author":"Tichy","year":"2006","journal-title":"Neoplasma"},{"key":"10.1016\/bs.acc.2018.10.005_bb0215","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1111\/bjh.12922","article-title":"Inter-laboratory discordance of beta-2 microglobulin results: impact on the validity of the international staging system for multiple myeloma","volume":"166","author":"Fedele","year":"2014","journal-title":"Br. J. Haematol."},{"key":"10.1016\/bs.acc.2018.10.005_bb0220","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/j.clinbiochem.2012.06.029","article-title":"Validating urinary measurement of beta-2-microglobulin with a Roche reagent kit designed for serum measurements","volume":"45","author":"Chan","year":"2012","journal-title":"Clin. Biochem."},{"key":"10.1016\/bs.acc.2018.10.005_bb0225","series-title":"The Certification of Mass Concentration of Beta-2-Microglobulin in Human Serum: ERM-DA470k\/IFCC","author":"Auclair","year":"2015"},{"key":"10.1016\/bs.acc.2018.10.005_bb0230","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0083-6729(00)58022-4","article-title":"Prostaglandin D synthase: structure and function","volume":"58","author":"Urade","year":"2000","journal-title":"Vitam. Horm."},{"key":"10.1016\/bs.acc.2018.10.005_bb0235","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/glycob\/7.4.499","article-title":"Molecular characterization of beta-trace protein in human serum and urine: a potential diagnostic marker for renal diseases","volume":"7","author":"Hoffmann","year":"1997","journal-title":"Glycobiology"},{"key":"10.1016\/bs.acc.2018.10.005_bb0240","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1053\/j.ajkd.2014.06.038","article-title":"Beta-trace protein: a marker of GFR and other biological pathways","volume":"65","author":"White","year":"2015","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/bs.acc.2018.10.005_bb0245","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.neures.2008.03.006","article-title":"Pharmacokinetics of recombinant human lipocalin-type prostaglandin D synthase\/\u03b2-trace in canine","volume":"61","author":"Li","year":"2008","journal-title":"Neurosci. Res."},{"key":"10.1016\/bs.acc.2018.10.005_bb0250","doi-asserted-by":"crossref","first-page":"5821","DOI":"10.1021\/cr2002992","article-title":"Enzymes of the cyclooxygenase pathways of prostanoid biosynthesis","volume":"111","author":"Smith","year":"2011","journal-title":"Chem. Rev."},{"key":"10.1016\/bs.acc.2018.10.005_bb0255","doi-asserted-by":"crossref","first-page":"126ra34","DOI":"10.1126\/scitranslmed.3003122","article-title":"Prostaglandin D2 inhibits hair growth and is elevated in bald scalp of men with androgenetic alopecia","volume":"4","author":"Garza","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/bs.acc.2018.10.005_bb0260","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0090-6980(02)00134-X","article-title":"Prostaglandin D2 synthase enzymes and PPAR\u03b3 are co-expressed in mouse 3T3-L1 adipocytes and human tissues","volume":"70","author":"Jowsey","year":"2003","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1016\/bs.acc.2018.10.005_bb0265","doi-asserted-by":"crossref","first-page":"15789","DOI":"10.1074\/jbc.272.25.15789","article-title":"Lipocalin-type prostaglandin D synthase (beta-trace) is a newly recognized type of retinoid transporter","volume":"272","author":"Tanaka","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/bs.acc.2018.10.005_bb0270","doi-asserted-by":"crossref","first-page":"8006","DOI":"10.1021\/bi990261p","article-title":"Binding of biliverdin, bilirubin, and thyroid hormones to lipocalin-type prostaglandin D synthase","volume":"38","author":"Beuckmann","year":"1999","journal-title":"Biochemistry"},{"key":"10.1016\/bs.acc.2018.10.005_bb0275","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1111\/j.1471-4159.1973.tb07570.x","article-title":"Metabolic studies on 125I-labelled beta-trace protein, with special reference to synthesis within the central nervous system","volume":"21","author":"Olsson","year":"1973","journal-title":"J. Neurochem."},{"key":"10.1016\/bs.acc.2018.10.005_bb0280","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000005553","article-title":"Urinary beta-trace protein: a unique biomarker to screen early glomerular filtration rate impairment","volume":"95","author":"Donadio","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/bs.acc.2018.10.005_bb0285","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1373\/clinchem.2007.090126","article-title":"A novel equation to estimate glomerular filtration rate using beta-trace protein","volume":"53","author":"White","year":"2007","journal-title":"Clin. Chem."},{"key":"10.1016\/bs.acc.2018.10.005_bb0290","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1111\/j.1600-6143.2007.02117.x","article-title":"Beta-trace protein-based equations for calculation of GFR in renal transplant recipients","volume":"8","author":"Poge","year":"2008","journal-title":"Am. J. Transplant."},{"key":"10.1016\/bs.acc.2018.10.005_bb0295","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1053\/j.ajkd.2015.07.025","article-title":"GFR estimation using beta-trace protein and beta2-microglobulin in CKD","volume":"67","author":"Inker","year":"2016","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/bs.acc.2018.10.005_bb0300","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1053\/j.ajkd.2009.06.003","article-title":"Effect of clinical variables and immunosuppression on serum cystatin C and beta-trace protein in kidney transplant recipients","volume":"54","author":"White","year":"2009","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/bs.acc.2018.10.005_bb0305","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1093\/ndt\/gfs591","article-title":"Genome-wide significant locus of beta-trace protein, a novel kidney function biomarker, identified in European and African Americans","volume":"28","author":"Tin","year":"2013","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/bs.acc.2018.10.005_bb0310","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1093\/clinchem\/48.5.729","article-title":"Beta-trace protein, cystatin C, beta(2)-microglobulin, and creatinine compared for detecting impaired glomerular filtration rates in children","volume":"48","author":"Filler","year":"2002","journal-title":"Clin. Chem."},{"key":"10.1016\/bs.acc.2018.10.005_bb0315","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/S0731-7085(03)00215-2","article-title":"Serum levels of beta-trace protein and glomerular filtration rate\u2014preliminary results","volume":"32","author":"Donadio","year":"2003","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/bs.acc.2018.10.005_bb0320","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1097\/01.ju.0000060205.23406.13","article-title":"Measuring glomerular filtration rate with cystatin C and beta-trace protein in children with spina bifida","volume":"169","author":"Pham-Huy","year":"2003","journal-title":"J. Urol."},{"key":"10.1016\/bs.acc.2018.10.005_bb0325","doi-asserted-by":"crossref","first-page":"584","DOI":"10.2215\/CJN.08700812","article-title":"Comparison of serum concentrations of \u03b2-trace protein, \u03b22-microglobulin, cystatin C, and creatinine in the US population","volume":"8","author":"Juraschek","year":"2013","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/bs.acc.2018.10.005_bb0330","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.clinbiochem.2007.11.012","article-title":"Beta-trace protein is not superior to cystatin C for the estimation of GFR in patients receiving corticosteroids","volume":"41","author":"Abbink","year":"2008","journal-title":"Clin. Biochem."},{"key":"10.1016\/bs.acc.2018.10.005_bb0335","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1373\/clinchem.2005.048959","article-title":"Beta-trace protein is an alternative marker for glomerular filtration rate in renal transplantation patients","volume":"51","author":"Poge","year":"2005","journal-title":"Clin. Chem."},{"key":"10.1016\/bs.acc.2018.10.005_bb0340","doi-asserted-by":"crossref","first-page":"644","DOI":"10.3899\/jrheum.090622","article-title":"Increased concentrations of prostaglandin D2 during post-fracture bone remodeling","volume":"37","author":"Gallant","year":"2010","journal-title":"J. Rheumatol."},{"key":"10.1016\/bs.acc.2018.10.005_bb0345","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.sleep.2006.10.005","article-title":"Prostaglandin D synthase (beta trace) levels in sleep apnea patients with and without sleepiness","volume":"8","author":"Barcelo","year":"2007","journal-title":"Sleep Med."},{"key":"10.1016\/bs.acc.2018.10.005_bb0350","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1373\/clinchem.2009.138826","article-title":"Serum creatinine, cystatin C, and beta-trace protein in diagnostic staging and predicting progression of primary nondiabetic chronic kidney disease","volume":"56","author":"Spanaus","year":"2010","journal-title":"Clin. Chem."},{"key":"10.1016\/bs.acc.2018.10.005_bb0355","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1053\/j.ajkd.2011.07.018","article-title":"Comparison of measured GFR, serum creatinine, cystatin C, and beta-trace protein to predict ESRD in African Americans with hypertensive CKD","volume":"58","author":"Bhavsar","year":"2011","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/bs.acc.2018.10.005_bb0360","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1053\/j.ajkd.2015.01.013","article-title":"Filtration markers as predictors of ESRD and mortality in Southwestern American Indians with type 2 diabetes","volume":"66","author":"Foster","year":"2015","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/bs.acc.2018.10.005_bb0365","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2215\/CJN.03660316","article-title":"Filtration markers as predictors of ESRD and mortality: individual participant data meta-analysis","volume":"12","author":"Inker","year":"2017","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/bs.acc.2018.10.005_bb0370","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/0140-6736(92)90865-Z","article-title":"Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure","volume":"339","author":"Vallance","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/bs.acc.2018.10.005_bb0375","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1440-1797.2012.01659.x","article-title":"Role of asymmetrical dimethylarginine in the progression of renal disease","volume":"18","author":"Raptis","year":"2013","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/bs.acc.2018.10.005_bb0380","doi-asserted-by":"crossref","first-page":"747","DOI":"10.2337\/dc07-1762","article-title":"Plasma concentration of asymmetric dimethylarginine (ADMA) predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy","volume":"31","author":"Lajer","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/bs.acc.2018.10.005_bb0385","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1681\/ASN.2005020179","article-title":"Asymmetric dimethylarginine and progression of chronic kidney disease: the mild to moderate kidney disease study","volume":"16","author":"Fliser","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/bs.acc.2018.10.005_bb0390","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1681\/ASN.2005010076","article-title":"Asymmetrical dimethylarginine predicts progression to dialysis and death in patients with chronic kidney disease: a competing risks modeling approach","volume":"16","author":"Ravani","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/bs.acc.2018.10.005_bb0395","first-page":"28","article-title":"Comparison of asymmetric dimethylarginine levels between stages three, four, and five non-dialysis of chronic kidney disease","volume":"48","author":"Asmarawati","year":"2016","journal-title":"Acta Med. Indones."},{"key":"10.1016\/bs.acc.2018.10.005_bb0400","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1258\/acb.2009.009196","article-title":"The biochemistry, measurement and current clinical significance of asymmetric dimethylarginine","volume":"47","author":"Blackwell","year":"2010","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/bs.acc.2018.10.005_bb0405","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.5301\/jn.5000085","article-title":"Measuring asymmetric dimethylarginine (ADMA) in CKD: a comparison between enzyme-linked immunosorbent assay and liquid chromatography-electrospray tandem mass spectrometry","volume":"25","author":"Pecchini","year":"2012","journal-title":"J. Nephrol."},{"key":"10.1016\/bs.acc.2018.10.005_bb0410","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1093\/ndt\/gfl292","article-title":"Symmetric dimethylarginine (SDMA) as endogenous marker of renal function\u2014a meta-analysis","volume":"21","author":"Kielstein","year":"2006","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/bs.acc.2018.10.005_bb0415","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/j.1365-2362.2010.02451.x","article-title":"Plasma dimethylarginines during the acute inflammatory response","volume":"41","author":"Blackwell","year":"2011","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/bs.acc.2018.10.005_bb0420","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1373\/clinchem.2010.150854","article-title":"Symmetrical and asymmetrical dimethylarginine as predictors for mortality in patients referred for coronary angiography: the Ludwigshafen Risk and Cardiovascular Health study","volume":"57","author":"Meinitzer","year":"2011","journal-title":"Clin. Chem."},{"key":"10.1016\/bs.acc.2018.10.005_bb0425","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.bbrc.2003.12.102","article-title":"FGF-23 transgenic mice demonstrate hypophosphatemic rickets with reduced expression of sodium phosphate cotransporter type IIa","volume":"314","author":"Shimada","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/bs.acc.2018.10.005_bb0430","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1681\/ASN.2014020218","article-title":"Serum fibroblast growth factor-23 is associated with incident kidney disease","volume":"26","author":"Rebholz","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/bs.acc.2018.10.005_bb0435","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1159\/000479300","article-title":"Fibroblast growth factor 23 predicts mortality and end-stage renal disease in a Canadian Asian population with chronic kidney disease","volume":"137","author":"Jialal","year":"2017","journal-title":"Nephron"},{"key":"10.1016\/bs.acc.2018.10.005_bb0440","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1159\/000488361","article-title":"Fibroblast growth factor 23 and renal function among young and healthy individuals","volume":"47","author":"Bernasconi","year":"2018","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/bs.acc.2018.10.005_bb0445","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1159\/000488361","article-title":"Fibroblast growth factor 23: a biomarker of kidney function decline","volume":"47","author":"Drew","year":"2018","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/bs.acc.2018.10.005_bb0450","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1007\/s11255-013-0451-x","article-title":"FGF23 concentrations measured using \u201cintact\u201d assays similar but not interchangeable","volume":"45","author":"Sinha","year":"2013","journal-title":"Int. Urol. Nephrol."},{"key":"10.1016\/bs.acc.2018.10.005_bb0455","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1074\/jbc.273.7.4135","article-title":"Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury","volume":"273","author":"Ichimura","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/bs.acc.2018.10.005_bb0460","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1053\/j.ajkd.2008.01.020","article-title":"Neutrophil gelatinase-associated lipocalin (NGAL) as a marker of kidney damage","volume":"52","author":"Bolignano","year":"2008","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/bs.acc.2018.10.005_bb0465","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1053\/j.ajkd.2012.05.014","article-title":"Associations of urinary levels of kidney injury molecule 1 (KIM-1) and neutrophil gelatinase-associated lipocalin (NGAL) with kidney function decline in the multi-ethnic study of atherosclerosis (MESA)","volume":"60","author":"Peralta","year":"2012","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/bs.acc.2018.10.005_bb0470","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1053\/j.ajkd.2016.08.022","article-title":"Urinary uromodulin and risk of urinary tract infections: the cardiovascular health study","volume":"69","author":"Garimella","year":"2017","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/bs.acc.2018.10.005_bb0475","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00240-015-0775-3","article-title":"An evaluation of Tamm-Horsfall protein glycans in kidney stone formers using novel techniques","volume":"43","author":"Argade","year":"2015","journal-title":"Urolithiasis"},{"key":"10.1016\/bs.acc.2018.10.005_bb0480","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1093\/ndt\/gfp748","article-title":"Evidence for a role of uromodulin in chronic kidney disease progression","volume":"25","author":"Prajczer","year":"2010","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/bs.acc.2018.10.005_bb0485","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000003011","article-title":"Plasma uromodulin correlates with kidney function and identifies early stages in chronic kidney disease patients","volume":"95","author":"Steubl","year":"2016","journal-title":"Medicine"},{"key":"10.1016\/bs.acc.2018.10.005_bb0490","first-page":"995","article-title":"Serum uromodulin concentrations correlate with glomerular filtration rate in patients with chronic kidney disease","volume":"126","author":"Fedak","year":"2016","journal-title":"Pol. Arch. Med. Wewn."},{"key":"10.1016\/bs.acc.2018.10.005_bb0495","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/HJH.0000000000001527","article-title":"The value of uromodulin as a new serum marker to predict decline in renal function","volume":"36","author":"Leiherer","year":"2018","journal-title":"J. Hypertens."},{"key":"10.1016\/bs.acc.2018.10.005_bb0500","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1093\/ndt\/gft345","article-title":"Determination of uromodulin in human urine: influence of storage and processing","volume":"29","author":"Youhanna","year":"2014","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/bs.acc.2018.10.005_bb0505","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1093\/ndt\/gfm541","article-title":"Urinary neutrophil gelatinase-associated lipocalin (NGAL) is associated with severity of renal disease in proteinuric patients","volume":"23","author":"Bolignano","year":"2008","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/bs.acc.2018.10.005_bb0510","doi-asserted-by":"crossref","first-page":"997","DOI":"10.2310\/JIM.0b013e31818e7e95","article-title":"Effect of a single intravenous immunoglobulin infusion on neutrophil gelatinase-associated lipocalin levels in proteinuric patients with normal renal function","volume":"56","author":"Bolignano","year":"2008","journal-title":"J. Invest. Med."},{"key":"10.1016\/bs.acc.2018.10.005_bb0515","doi-asserted-by":"crossref","first-page":"6481","DOI":"10.1128\/JVI.03156-14","article-title":"Interaction between TIM-1 and NPC1 is important for cellular entry of Ebola virus","volume":"89","author":"Kuroda","year":"2015","journal-title":"J. Virol."},{"issue":"Suppl. 1","key":"10.1016\/bs.acc.2018.10.005_bb0520","first-page":"S14","article-title":"The role of NAG (N-acetyl-beta-d-glucosaminidase) in the diagnosis of kidney disease including the monitoring of nephrotoxicity","volume":"38","author":"Price","year":"1992","journal-title":"Clin. Nephrol."},{"key":"10.1016\/bs.acc.2018.10.005_bb0525","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0167334","article-title":"Are urinary tubular injury markers useful in chronic kidney disease? A systematic review and meta analysis","volume":"11","author":"Zhou","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/bs.acc.2018.10.005_bb0530","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1681\/ASN.2008030312","article-title":"Podocyte-selective deletion of dicer induces proteinuria and glomerulosclerosis","volume":"19","author":"Shi","year":"2008","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/bs.acc.2018.10.005_bb0535","doi-asserted-by":"crossref","first-page":"e188","DOI":"10.1093\/nar\/gnh186","article-title":"Development of a micro-array to detect human and mouse microRNAs and characterization of expression in human organs","volume":"32","author":"Sun","year":"2004","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/bs.acc.2018.10.005_bb0540","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1101\/gr.6587008","article-title":"MicroRNA-target pairs in the rat kidney identified by microRNA microarray, proteomic, and bioinformatic analysis","volume":"18","author":"Tian","year":"2008","journal-title":"Genome Res."},{"key":"10.1016\/bs.acc.2018.10.005_bb0545","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.fct.2016.02.018","article-title":"MicroRNA biomarkers in clinical renal disease: from diabetic nephropathy renal transplantation and beyond","volume":"98","author":"Nassirpour","year":"2016","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/bs.acc.2018.10.005_bb0550","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1681\/ASN.2010020134","article-title":"miR-192 mediates TGF-beta\/Smad3-driven renal fibrosis","volume":"21","author":"Chung","year":"2010","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/bs.acc.2018.10.005_bb0555","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1046\/j.1523-1755.1998.06812.x","article-title":"Therapeutic implications and new perspectives for essential hypertension and renal damage","volume":"68","author":"Gonzalez-Albarran","year":"1998","journal-title":"Kidney Int. Suppl."},{"key":"10.1016\/bs.acc.2018.10.005_bb0560","article-title":"Decreased microRNA is involved in the vascular remodeling abnormalities in chronic kidney disease (CKD)","volume":"8","author":"Chen","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/bs.acc.2018.10.005_bb0565","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.1093\/ndt\/gfr485","article-title":"Circulating microRNA expression is reduced in chronic kidney disease","volume":"26","author":"Neal","year":"2011","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/bs.acc.2018.10.005_bb0570","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1261\/rna.058834.116","article-title":"Identification of urinary exosomal noncoding RNAs as novel biomarkers in chronic kidney disease","volume":"23","author":"Khurana","year":"2017","journal-title":"RNA"},{"key":"10.1016\/bs.acc.2018.10.005_bb0575","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.crvi.2016.12.001","article-title":"Les microRNA comme biomarqueurs: quelles perspectives?","volume":"340","author":"Zendjabil","year":"2017","journal-title":"C. R. Biol."},{"key":"10.1016\/bs.acc.2018.10.005_bb0580","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1093\/ndt\/gfn739","article-title":"Increased indoleamine 2,3-dioxygenase (IDO) activity and elevated serum levels of tryptophan catabolites in patients with chronic kidney disease: a possible link between chronic inflammation and uraemic symptoms","volume":"24","author":"Schefold","year":"2009","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/bs.acc.2018.10.005_bb0585","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1681\/ASN.2014111099","article-title":"A metabolome-wide association study of kidney function and disease in the general population","volume":"27","author":"Sekula","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/bs.acc.2018.10.005_bb0590","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/978-1-4684-5952-4_45","article-title":"Kynurenine and lipid metabolism","volume":"294","author":"Rudzite","year":"1991","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/bs.acc.2018.10.005_bb0595","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3109\/1354750X.2013.790074","article-title":"Serum levels and activity of indoleamine2,3-dioxygenase and tryptophanyl-tRNA synthetase and their association with disease severity in patients with chronic kidney disease","volume":"18","author":"Bao","year":"2013","journal-title":"Biomarkers"},{"key":"10.1016\/bs.acc.2018.10.005_bb0600","doi-asserted-by":"crossref","DOI":"10.1177\/1178646917694600","article-title":"Tryptophan metabolism in patients with chronic kidney disease secondary to type 2 diabetes: relationship to inflammatory markers","volume":"10","author":"Debnath","year":"2017","journal-title":"Int. J. Tryptophan Res."},{"key":"10.1016\/bs.acc.2018.10.005_bb0605","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.2215\/CJN.11971113","article-title":"Serum metabolomic profiling and incident CKD among African Americans","volume":"9","author":"Yu","year":"2014","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/bs.acc.2018.10.005_bb0610","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cca.2013.03.033","article-title":"Metabolomics in chronic kidney disease","volume":"422","author":"Zhao","year":"2013","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/bs.acc.2018.10.005_bb0615","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.abb.2015.07.018","article-title":"Metabolic biomarkers for chronic kidney disease","volume":"589","author":"Breit","year":"2016","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/bs.acc.2018.10.005_bb0620","doi-asserted-by":"crossref","DOI":"10.1016\/S2214-109X(14)70002-6","article-title":"The epidemiology of chronic kidney disease in sub-Saharan Africa: a systematic review and meta-analysis","volume":"2","author":"Stanifer","year":"2014","journal-title":"Lancet Glob. Health"}],"container-title":["Advances in Clinical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S006524231830057X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S006524231830057X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T19:36:42Z","timestamp":1758742602000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S006524231830057X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"ISBN":["9780128171431"],"references-count":123,"URL":"https:\/\/doi.org\/10.1016\/bs.acc.2018.10.005","relation":{},"ISSN":["0065-2423"],"issn-type":[{"value":"0065-2423","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]}}}